US ClosedU.S. Closed
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide.
52W Range
Volume
Mkt Cap
P/E
Div Yield